Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Recruiting now

Conditions studied: Cervical Cancer, Cervical Dysplasia, Oropharyngeal Cancer, Human Papillomavirus Infection

In brief

This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.

Key facts

Study ID

NCT05774561

Run by

The Institute of Molecular and Translational Medicine, Czech Republic

People needed

480

Starts

2022-06-01

Expected to finish

2026-12-01

Last updated by the study team

2026-02-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Women diagnosed with CC/HSIL. Men and women diagnosed with OPC. Patients must agree with study enrollment and must sign study informed consent.

You may not qualify if…

• No exclusion criteria are set.

Where it is running

• University Hospital Olomouc — Olomouc, Czechia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.